1. |
Oner FA, Yurdakul S, Oner E, et al. Evaluation of the effect of L-thyroxin therapy on cardiac functions by using novel tissue doppler-derived indices in patients with subclinical hypothyroidism[J]. Acta Cardiol, 2011, 66(1):47-55.
|
2. |
Rotondi M, Magri F, Chiovato L. Risk of coronary heart disease and mortality for adults with subclinical hypotyroidism[J]. JAMA, 2010, 304(22):2481-2482.
|
3. |
Tagami T, Tamanaha T, Shimazu S, et al. Lipid profiles in the untreated patients with Hashimoto thyroiditis and the effects of thyroxine treatment on subclinical hypothyroldism with Hashimoto thyroiditis[J]. Endocr J, 2010, 57(1):253-258.
|
4. |
Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994):National Health and Nutrition Examination Survey (NHANES Ⅲ)[J]. J Clin Endocrinol Metab, 2002, 87(2):489-499.
|
5. |
Wang F, Tan Y, Wang C, et al. Thyroid-stimulating hormone levels within the reference range are associated with serum lipid profiles independent of thyroid hormones[J]. J Clin Endocrinol Metab, 2012, 97(8):2724-2731.
|
6. |
Tian L, Song Y, Xing M, et al. A novel role for thyroid-stimulating hormone:up-regulation of hepatic 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase expression through the cyclic adenosine monophosphate/protein kinase A/cyclic adenosine monophosphate-responsive element binding protein pathway[J]. Hepatology, 2010, 52(4):1401-1409.
|
7. |
Monzani F, Del GP, Caraccio N, et al. Subclinical hypothyroidism:neurobehavioral features and beneficial effect of L-thyroxine treatment[J]. Clin Investig, 1993, 71(5):367-371.
|
8. |
张国峰. 左甲状腺素对甲状腺功能减退症及亚临床甲状腺功能减退症患者血脂的影响[J]. 中国全科医学, 2010, 13(7B):2213-2215.
|
9. |
董梅, 齐宝庆. 亚临床甲状腺功能减退症的研究进展[J]. 内科, 2008, 3(5):767.
|